Roche receives USFDA’s priority review to Xolair for food allergies based on positive NIH Phase III study results
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
The establishment of the facility demonstrates the company's commitment to delivering differentiated solutions to gynecology and pediatrics challenges
The plant is yet to start commercial operations
World HRD Congress is a well-known international body of Management Studies
If approved, patritumab deruxtecan would be a first-in-class HER3 directed DXd antibody drug conjugate for these patients
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
Trinity has availed credit facility from Investec for Business for their working capital requirements of Rs. 31.5 crore
Softovac Liquifibre expands the Softovac product portfolio and provides a choice for consumers who prefer time-tested Ayurvedic ingredients
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
Subscribe To Our Newsletter & Stay Updated